Reinhard Mark, Frystyk Jan, Jespersen Bente, Randers Else, Bjerre Mette, Christiansen Jens S, Flyvbjerg Allan, Bibby Bo M, Ivarsen Per
Department of Renal Medicine, Aarhus University Hospital, Aarhus C, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus C, Denmark.
Clin Endocrinol (Oxf). 2014 May;80(5):757-65. doi: 10.1111/cen.12352. Epub 2013 Nov 19.
Patients on maintenance haemodialysis (HD) have reduced circulating free and bioactive insulin-like growth factor I (IGF-I) due to increased IGF-binding proteins (IGFBPs). This study investigated the postprandial response of the IGF system in HD patients compared with matched healthy subjects.
In a crossover study, twelve nondiabetic HD patients were assigned in a random order to three 10-h study days: (1) a non-HD day with one meal served at baseline (NHDM1), (2) an HD day with one meal served during HD (HDM1) and (3) an HD day with two meals served during and after HD, respectively (HDM2). Twelve healthy controls conducted session 1.
After the baseline meal, insulin concentrations changed similarly in HD patients and controls, whereas hyperglycaemia was more prolonged in HD patients (P < 0·001). Postprandial IGFBP-1 showed greater reductions from baseline in controls (-76% [-81; -70%], mean [95% confidence intervals], P < 0·001) than in patients on non-HD days (-45% [-57; -30%], P < 0·001). In the latter group, the response was even more attenuated during HD (-22% [-38; -1%] and -24% [-40; -4%], P ≤ 0·041). After the second meal on HDM2 days, IGFBP-1 further decreased (-50% [-61; -37%], P < 0·001), whereas IGFBP-1 returned to baseline levels on the other study days. Consistently, at the end of the study days, bioactive IGF-I was significantly above baseline only on HDM2 days (+22% [+5; +43%], P = 0·012).
HD patients were unable to suppress IGFBP-1 to the same extent as healthy controls, which may increase the risk of protein-energy wasting in maintenance HD. A second meal after HD, however, effectively suppressed IGFBP-1 and increased bioactive IGF-I.
维持性血液透析(HD)患者由于胰岛素样生长因子结合蛋白(IGFBPs)增加,循环中的游离和生物活性胰岛素样生长因子I(IGF-I)减少。本研究调查了HD患者与匹配的健康受试者相比,IGF系统的餐后反应。
在一项交叉研究中,12名非糖尿病HD患者被随机安排到三个10小时的研究日:(1)非HD日,在基线时提供一餐(NHDM1);(2)HD日,在HD期间提供一餐(HDM1);(3)HD日,分别在HD期间和HD后提供两餐(HDM2)。12名健康对照者进行第1阶段。
基线餐后,HD患者和对照者的胰岛素浓度变化相似,而HD患者的高血糖持续时间更长(P<0.001)。餐后IGFBP-1在对照者中从基线的降低幅度大于非HD日的患者(分别为-76%[-81;-70%],平均值[95%置信区间],P<0.001和-45%[-57;-30%],P<0.001)。在后者组中,HD期间反应进一步减弱(分别为-22%[-38;-1%]和-24%[-40;-4%],P≤0.041)。在HDM2日的第二餐后,IGFBP-1进一步降低(-50%[-61;-37%],P<0.001),而在其他研究日IGFBP-1恢复到基线水平。一致地,在研究日结束时,仅在HDM2日生物活性IGF-I显著高于基线水平(+22%[+5;+43%],P=0.012)。
HD患者无法像健康对照者那样程度地抑制IGFBP-1,这可能增加维持性HD患者蛋白质-能量消耗的风险。然而HD后第二餐可有效抑制IGFBP-1并增加生物活性IGF-I。